Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-010505
Filing Date
2013-08-12
Accepted
2013-08-12 16:08:07
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20130630_10q.htm 10-Q 484161
2 EXHIBIT 31.1 ex31-1.htm EX-31 15333
3 EXHIBIT 31.2 ex31-2.htm EX-31 15461
4 EXHIBIT 32.1 ex32-1.htm EX-32 4522
5 EXHIBIT 32.2 ex32-2.htm EX-32 4488
  Complete submission text file 0001437749-13-010505.txt   2937792

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS govx-20130630.xml EX-101.INS 189740
7 EXHIBIT 101.SCH govx-20130630.xsd EX-101.SCH 24888
8 EXHIBIT 101.CAL govx-20130630_cal.xml EX-101.CAL 19976
9 EXHIBIT 101.DEF govx-20130630_def.xml EX-101.DEF 100021
10 EXHIBIT 101.LAB govx-20130630_lab.xml EX-101.LAB 178035
11 EXHIBIT 101.PRE govx-20130630_pre.xml EX-101.PRE 104909
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52091 | Film No.: 131029884
SIC: 8731 Services-Commercial Physical & Biological Research